Based on the provided abstracts, the MIA gene encodes a secreted protein with growth inhibitory effects on melanoma cells and other neuroectodermal tumors including gliomas 1. The MIA gene consists of four exons with an mRNA initiation site located 70 base pairs upstream from the translation start codon 1. Expression analysis reveals that MIA mRNA levels correlate with progressive malignancy of melanocytic lesions in vivo and can be induced by phorbol ester treatment 1. The gene's promoter contains an NF-κB binding site that contributes to basal promoter activity specifically in melanoma cells, though phorbol ester enhancement appears to be mediated through additional regulatory elements 1. However, the provided abstracts contain limited information about the specific molecular mechanisms underlying MIA's growth inhibitory function or its broader physiological roles beyond melanoma. The disease relevance appears primarily focused on melanoma and related neuroectodermal tumors, where MIA may function as a tumor suppressor. Clinical significance remains unclear from the available literature, as most abstracts discuss unrelated research using 'MIA' as an acronym for other concepts rather than the MIA SH3 domain containing gene.